XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results. - Cassidy, J.; Clarke, S.; D&a#x00ED;az-Rubio, E.; Scheithauer, W.; Figer, A.; Wong, R.; Koski, S.; Rittweger, K.; Gilberg, F.; Saltz, L.; Díaz-Rubio, E (British Journal of Cancer, 2011)